Efficacy of low dose budesonide inhalation suspension / sodium cromoglicate inhalation solution for mild / moderate persistent asthma in young children - Efficacy of low dose budesonide inhalation for mild / moderate persistent asthma in young children (Mild One Study)

Mild One research society0 个研究点目标入组 40 人2010年1月21日

概览

阶段: 未知
干预措施: 未指定
疾病 / 适应症: 未指定
发起方: Mild One research society
入组人数: 40
状态: 已完成
最后更新: 2年前

概览研究者入排标准结局指标相似试验

概览

简要总结

暂无简介。

注册库

who.int

开始日期

2010年1月21日

结束日期

2010年8月1日

最后更新

2年前

研究类型

Interventional

性别

All

研究者

发起方

Mild One research society

入排标准

入选标准

未提供

排除标准

•1\. Patients who have a case listed below within a month a)Severe respiratory infection disease that required hospitalization b)Administration of systemic steroid 2\. Patients who have underlying disease that indicate chronic airway symptom exclude asthma

结局指标

主要结局

未指定

相似试验

已完成

不适用

Evaluation of efficacy of budesonide inhalation suspension for infants with severe intermittent asthma - A multicenter, open, randomized, parallel-group studybronchial asthma

JPRN-UMIN000001557Mie National Hospital80

已完成

不适用

Therapeutic efficacy of budesonide inhalation suspension for moderate bronchial asthma attacks as a substitute for steroid injectio

JPRN-UMIN000012722ational Hospital Organization Sagamihara National Hospital100

进行中（未招募）

1 期

Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia - NEUROSISHigh risk of bronchopulmonary dysplasia in very preterm neonatesMedDRA version: 12.1Level: LLTClassification code 10006475Term: Bronchopulmonary dysplasia

EUCTR2009-012203-26-EEniversitätsklinikum Tübingen863

进行中（未招募）

1 期

Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia - NEUROSIS

EUCTR2009-012203-26-DEniversity Children's Hospital, Department of Neonatology850

进行中（未招募）

1 期

Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary DysplasiaSurvival of extremely Low Birth Weight (ELBW) infants has improved in recent decades but Bronchopulmonary Dysplasia (BPD) remains a major health care problem. BPD is a chronic lung disease that occurs in premature infants requiring mechanical ventilation and oxygen therapy, but also develops in preterm neonates who require little or no ventilatory or oxygen supportMedDRA version: 14.1Level: PTClassification code 10006475Term: Bronchopulmonary dysplasiaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]

EUCTR2009-012203-26-BEniversity Children’s Hospital, Department of Neonatology850